Free Trial

Lecap Asset Management Ltd. Invests $978,000 in Chemed Corporation $CHE

Chemed logo with Medical background

Key Points

  • Lecap Asset Management Ltd. has invested $978,000 in Chemed Corporation by acquiring 2,009 shares, according to a recent SEC filing.
  • Chemed's stock has seen a 0.2% increase recently and has a current market capitalization of $6.43 billion.
  • The company recently announced an increase in its dividend to $0.60 per share, up from $0.50, reflecting a growing payout ratio of 12.34%.
  • Five stocks to consider instead of Chemed.

Lecap Asset Management Ltd. acquired a new stake in shares of Chemed Corporation (NYSE:CHE - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 2,009 shares of the company's stock, valued at approximately $978,000.

A number of other hedge funds have also recently bought and sold shares of the company. Whipplewood Advisors LLC raised its holdings in Chemed by 54.5% in the 1st quarter. Whipplewood Advisors LLC now owns 51 shares of the company's stock valued at $31,000 after acquiring an additional 18 shares during the last quarter. Renasant Bank increased its stake in Chemed by 2.3% in the first quarter. Renasant Bank now owns 815 shares of the company's stock valued at $501,000 after purchasing an additional 18 shares during the last quarter. Impact Capital Partners LLC lifted its position in Chemed by 2.7% during the first quarter. Impact Capital Partners LLC now owns 763 shares of the company's stock worth $469,000 after buying an additional 20 shares during the period. Cim LLC boosted its stake in Chemed by 1.0% in the 1st quarter. Cim LLC now owns 2,029 shares of the company's stock worth $1,248,000 after buying an additional 21 shares during the last quarter. Finally, KFG Wealth Management LLC grew its holdings in Chemed by 4.6% in the 1st quarter. KFG Wealth Management LLC now owns 525 shares of the company's stock valued at $323,000 after buying an additional 23 shares during the period. Institutional investors and hedge funds own 95.85% of the company's stock.

Insider Buying and Selling

In related news, Director George J. Walsh III bought 200 shares of the firm's stock in a transaction dated Monday, August 4th. The stock was bought at an average price of $417.10 per share, with a total value of $83,420.00. Following the completion of the transaction, the director directly owned 3,523 shares of the company's stock, valued at approximately $1,469,443.30. This represents a 6.02% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Nicholas Michael Westfall sold 10,012 shares of the stock in a transaction dated Monday, August 4th. The shares were sold at an average price of $421.91, for a total value of $4,224,162.92. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 13,162 shares of company stock worth $5,677,511. Company insiders own 3.29% of the company's stock.

Chemed Stock Up 0.2%

Shares of CHE stock opened at $441.44 on Friday. Chemed Corporation has a fifty-two week low of $408.42 and a fifty-two week high of $623.60. The firm's 50 day moving average price is $449.24 and its two-hundred day moving average price is $517.53. The stock has a market cap of $6.43 billion, a price-to-earnings ratio of 22.70, a price-to-earnings-growth ratio of 2.56 and a beta of 0.43.

Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The company reported $4.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.02 by ($1.75). The business had revenue of $618.80 million during the quarter, compared to analyst estimates of $650.60 million. Chemed had a return on equity of 25.83% and a net margin of 11.56%.Chemed's revenue was up 3.8% on a year-over-year basis. During the same period in the previous year, the company earned $5.47 EPS. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. On average, equities analysts forecast that Chemed Corporation will post 21.43 EPS for the current fiscal year.

Chemed Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Shareholders of record on Monday, August 11th were paid a dividend of $0.60 per share. This is a boost from Chemed's previous quarterly dividend of $0.50. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date was Monday, August 11th. Chemed's payout ratio is presently 12.34%.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on CHE shares. Wall Street Zen lowered shares of Chemed from a "buy" rating to a "hold" rating in a report on Saturday, July 5th. Royal Bank Of Canada dropped their price target on shares of Chemed from $640.00 to $589.00 and set an "outperform" rating for the company in a research report on Thursday, July 31st. Oppenheimer decreased their price target on shares of Chemed from $650.00 to $580.00 and set an "outperform" rating on the stock in a report on Thursday, July 31st. Jefferies Financial Group raised shares of Chemed from a "hold" rating to a "buy" rating and boosted their price objective for the company from $490.00 to $550.00 in a research note on Tuesday, September 2nd. Finally, Bank of America dropped their price objective on Chemed from $610.00 to $595.00 and set a "buy" rating for the company in a report on Wednesday, September 10th. Four investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus price target of $578.50.

Get Our Latest Research Report on Chemed

About Chemed

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Read More

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Chemed Right Now?

Before you consider Chemed, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.

While Chemed currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.